A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Prediabetes is almost always a precursor to type 2 diabetes — but it doesn’t have to lead to that outcome. Experts share healthy steps to reverse the condition.

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Diabetes is one of the most common chronic diseases which is encountered in our day to day life. Patients with diabetes ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Diabetes is one of the most common chronic illnesses impacting daily lives. Medically, diabetes is classified into two ...